Dr. Lakshmi Kotra, Senior Scientist at Krembil Brain Institute, University Health Network (UHN), and Professor of Medicinal Chemistry at the University of Toronto, joined FSD Pharma as CEO of its wholly-owned subsidiary, Lucid, upon completion of its acquisition of Lucid Psycheceuticals in September 2021.
Sign up to view 0 direct reports
Get started